European Institute of Oncology: Breast Neoplasms trials
The registry lists 54 Breast Neoplasms studies with European Institute of Oncology as lead sponsor. 33 are open to participants now and 0 have results posted.
Phase 2 10Phase 3 3No phase 41(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dermatological Effects and Quality of Life in Oncology PatientsNot yet recruitingNCT07869186Not applicable
- Endoscopic Video-Assisted Nipple-Sparing MastectomyRecruitingNCT07579117Not applicable
- Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)RecruitingNCT07395336Phase 2
- Minimal Residual Disease in Solid MalignanciesNot yet recruitingNCT07268469Not applicable
- Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast CancerRecruitingNCT07049133
- Emotional Distress in Patients With Metastatic Breast Cancer in First Line of TherapyRecruitingNCT06994377
- Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast CancerRecruitingNCT06790264Not applicable
- A New Tool to Promote Patient's Engagement in Their Healthcare ProcessRecruitingNCT06762496
- Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,RecruitingNCT06762483
- Hemopatch Implication After Axillary Dissection for Breast CancerNot yet recruitingNCT06744998Not applicable
- Increasing Oral Medication Adherence for Metastatic Breast Cancer PatientsRecruitingNCT06726889
- IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4RecruitingNCT06703567Not applicable
- Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer PatientsRecruitingNCT06690840Phase 2
- Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast CancerNot yet recruitingNCT06611514Phase 3
- Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast CancerRecruitingNCT06610565Not applicable
- Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer PatientsRecruitingNCT06474988
- Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast CancerNot yet recruitingNCT06474975Not applicable
- Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral NeuropathyNot yet recruitingNCT06422949Not applicable
- A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast CancerRecruitingNCT06343181
- Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BCRecruitingNCT06340386
- CARDIOCARE Prospective Clinical StudyRecruitingNCT06334445
- PrefeRences And ChemoTherapy In Breast Cancer patiEntsRecruitingNCT06332976
- Psychosexuological Interventions to Support Sexual Function in Breast Cancer PatientsRecruitingNCT06327607
- Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph NodesRecruitingNCT06321653
- Contrast-Enhanced Spectral Mammography (CESM)RecruitingNCT06311695Phase 2
- Percutaneous Cryoablation of Low-risk Early Breast CancerRecruitingNCT06300125
- Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast SurgeryRecruitingNCT06281210Not applicable
- RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)RecruitingNCT05963464
- Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE BackRecruitingNCT05095675
- Single Fraction Preoperative Radiotherapy for Early Stage Breast CancerRecruitingNCT04679454Not applicable
- Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingNCT04304352Phase 2
- Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerRecruitingNCT03971045Phase 2
- Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast CancerRecruitingNCT03920488
- Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARPActive, not recruitingNCT06727357Phase 2
- Multimedia-assisted Informed Consent Procedure for Patients Undergoing Mastectomy and Implant-based ReconstructionCompletedNCT06541223
- Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the BoneActive, not recruitingNCT06321666Not applicable
- Enhancing Therapy Adherence Among Metastatic Breast Cancer PatientsCompletedNCT06161181Not applicable
- Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based ReconstructionCompletedNCT06139588
- Clinical Outcomes of Patients Undergoing Skin-Reducing MastectomiesCompletedNCT06133452
- Analysis of Breast-Conserving Surgery Plus Whole-Breast Irradiation Versus MastectomyCompletedNCT05126667
- Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)Active, not recruitingNCT04365803
- Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast CancerActive, not recruitingNCT03939156
- CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCERActive, not recruitingNCT03712956Phase 2
- Robotic Nipple-Sparing Mastectomy Vs Conventional Open TechniqueCompletedNCT03440398Not applicable
- Life ImproVed by Exercise (LIVE Trial)CompletedNCT02637765Not applicable
- Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast CancerCompletedNCT02622711Not applicable
- Sentinel Node Vs Observation After Axillary Ultra-souNDActive, not recruitingNCT02167490Not applicable
- Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External RadiotherapyCompletedNCT01849133Not applicable
- Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) UsersActive, not recruitingNCT01579734Phase 3
- A Prevention Trial in Subjects at High Risk for Breast CancerCompletedNCT01500577Phase 2
- Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerTerminatedNCT01375023Phase 2
- Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast CarcinomaCompletedNCT00970983Not applicable
- Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast CancerCompletedNCT00301548Phase 2
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast CancerCompletedNCT00002720Phase 3